7th Obesity and NASH Summit

Conference themes
Eli Lilly's 'triple G' drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for the obesity field has been set and the time to get ahead of the curve is now.

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/1972456-3?pid=4832

Speakers: Ana Paula Cancino, Global Executive Medical Director, Obesity, Amgen, Brian Finan, Vice President, Obesity, Novo Nordisk, Cindy Hartsfield, Director, Medical Affairs, 89bio, and more.

https://go.evvnt.com/1972456-2?pid=4832

Ms. Rona Perry